Skip to content

Carol G. Simon Cancer Center

Supported by the Carol G. Simon Cancer Center Philanthropy Council and our community of donors, Carol G. Simon Cancer Center at Morristown Medical Center is a nationally-recognized leader in fighting cancer with a medical team renowned for providing compassionate care using the latest technology and treatments.

Awards & Accolades

  • Lead affiliate of the only New Jersey-based National Community Oncology Research Program designated by the National Cancer Institute

    – National Cancer Institute

  • Best Regional Hospital, high performing in colon cancer surgery and leukemia, lymphoma & myeloma

    – U.S. News & World Report

  • High performing in gynecological cancer surgery, lung cancer surgery and prostate cancer surgery

    – U.S. News & World Report

  • Ranked #40 in the country and top two in NJ for Cancer care.

    – Money

  • Reaccreditation in recognition of high-quality, patient-centered cancer care

    – American College of Surgeons’ Commission on Cancer

In 2024, the enormous support you showed in bringing proton therapy to Carol G. Simon Cancer Center will transform lives next year and well into the future. Your generosity is helping to further cutting-edge technology, programs, research opportunities and clinical trials that allow our team to provide the best patient-centric care possible.

Eric D. Whitman, MD, FACS

System Medical Director, Atlantic Health System Cancer Care
Principal Investigator, Atlantic Health Cancer Consortium Community Oncology Research Program
Director, Atlantic Melanoma Center

Featured Campaign

Proton Therapy Center

$12,500,000

raised toward $12,500,000 goal

Thank you to our donors, including:

  • Margaret A. Darrin Charitable Trust
  • The Ferreira Family
  • Gagnon Family Foundation
  • The Carl J. Goldberg Family Charitable Fund
  • The Douglas M. Noble Family Foundation
  • The Hampshire Foundation
  • Robert and Catherine Tafaro
  • Women’s Association for Morristown Medical Center

In 2024, Foundation for Morristown Medical Center’s donors put resounding support behind bringing proton therapy to Morristown Medical Center when they met the $12.5 million goal to ensure the MEVION S250-FIT Proton Therapy System™ is available to cancer patients. This state-of-the-art technology allows for precise targeting that significantly enhances patient comfort and treatment outcomes. Proton therapy is particularly beneficial for patients with head and neck cancer, brain tumors, liver and lung cancer and tumors in children, as it reduces collateral damage to surrounding structures. Proton therapy will be available at Morristown Medical Center in 2026.

MEVION S250-FIT Proton Therapy System™

Lead Proton Therapy Center Donors

Thanks to the generosity of our leadership donors and additional support from the community, more than $12.5 million was donated in just a few short months to reach the project’s goal.

Leadership giving includes contributions from the Gagnon Family Foundation, the Margaret A. Darrin Charitable Trust, the Ferreira family, the Chair of the Foundation for Morristown Medical Center Board of Trustees Carl J. Goldberg and past Chair Robert Tafaro and his wife Catherine. Additional generous support comes from The Hampshire Foundation and the Douglas M. Noble Family Foundation, along with many others.

This combined philanthropy is a testament to the power of giving, helping transform cancer care and survivorship for countless patients in our communities and pave the way for a new era of cutting-edge radiation oncology services

2025 Mansion in May: Wildfair

Photo Credit: Heather Swartz

The Women’s Association for Morristown Medical Center has named the Proton Therapy Center at Carol G. Simon Cancer Center the beneficiary of its 2025 Mansion in May Designer Showhouse and Gardens. This signature event takes place every other year and provides a significant source of support for philanthropic initiatives at Morristown Medical Center.

Read More

Equipment Highlights

  • Hologic Mammography Machine

    Thanks to philanthropy from Eva J. Cantor, Esq., and Richard and Poppy Segal, Morristown Medical Center purchased a state-of-the-art 3D mammography unit for the Carol W. and Julius A. Rippel Breast Center to increase the number of screenings by 20 percent in the first two years of use alone. This technology is better at detecting cancer and reducing false-positive results, so the exponential growth in screening demands will be met with accuracy and care.  

Program Highlights

  • The Nurse Navigator for Women’s Cancer, whose position is donor-funded, uses extensive knowledge of gynecologic cancer and support resources to be a patient advocate, providing individualized care to each patient from the time of diagnosis through survivorship. These services are available to all gynecologic patients at Carol G. Simon Cancer Center, with no fees or medical insurance required.

  • The breast cancer social worker – a position made possible by a generous donation from CGSCC Philanthropy Council member Gita Rothschild-Berry – provides psychosocial support to patients and families with breast cancer diagnosis. They assess patient and family needs, develop a comprehensive care plan, connect patients and families to individual and group psychoeducational support programs and provide short term counseling and referrals to community resources. This team member also collaborates with other departments on breast cancer awareness and education.

fund highlights

  • The integrative medicine inpatient program, one of the largest in the country, expanded services into the inpatient cancer unit to allow for continuity of patient care and reduce the stress and anxiety related to hospitalization and a cancer diagnosis. Patients who receive integrative medicine treatment have a reduction of 40 percent or more in their anxiety, pain and nausea. Thanks to Linda Spohler and other thoughtful donors, this program offers services such as massage, energy work, art therapy, music therapy, spiritual care and nutritional consultations.

  • Generous funding from Grace and James Woo is supporting the Atlantic Cancer Research Institute (ACRI) fund, which will further the development of a core research facility and program led by Morristown Medical Center oncology specialists. The research supported by this fund will leverage the unique specialty focuses of Morristown Medical Center physicians, especially in gastrointestinal (GI) cancers, including gastric and pancreatic cancer, melanoma/skin cancers, gynecologic cancers, leukemia/lymphoma, head/neck cancers and sarcomas.

  • With funding from donors such as the Estate of Marilyn C. Shulman, Morristown Medical Center’s Oncology Research Department is advancing several physician-initiated trials, supporting an Ovarian Screening Trial with MD Anderson Cancer Center and working to meet the growing need for expanded access and compassion use products in cancer care.

  • Funding from 2024 will support a Pancreatic Cancer Early Detection Clinical Trial, which is a three-year pilot research project that will use biomarkers to determine the presence of cancer or evaluate risk in addition to CT scans, MRIs and advanced endoscopy. Donations will cover imaging as well as salaries for research team members.